CORC

在结果中检索

CORC

浏览/检索结果: 共156条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non- small cell lung cancer (EMERGING): A randomised study 会议论文
作者:  Zhong, W-Z.;  Wu, Y-L.;  Chen, K-N.;  Chen, C.;  Gu, C-D.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Stat4 deficiency exacerbates atherosclerosis through promoting foam cell formation via pi3k/akt/nfkb/mir-9/acat1 pathway in ApoE-/- mice 会议论文
作者:  Xu, L.;  Ding, S.;  Yang, X.;  Ge, J.
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
The treatment of acral vitiligo with autologous cultured epidermal grafts 会议论文
作者:  Chen, S.;  Li, J.;  Zhu, Q.;  Yang, K.;  Tang, L.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Application of Radiomics Signature Captured from Pretreatment CT to Predict Brain Metastases in Stage III/IV Non-small Cell Lung Cancer Patients with ALK Mutation 会议论文
作者:  Wen, J.;  Xie, L.;  Liu, D.;  Fan, M.;  Zhang, J.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
A novel method of measuring exosomal HER2 to assist in selecting advanced gastric cancer patients benefiting from anti-HER2 therapy 会议论文
作者:  Cai, S.;  Li, Q.;  Xu, X.;  Yu, Y.;  Li, W.
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
Palliative Radiation Therapy for metastatic Primary Signet Ring Cell Carcinoma of the Lung: A SEER Analysis 会议论文
作者:  Wen, J.;  Xu, X.;  Chen, J.;  Liu, D.;  Xie, L.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) in patients with refractory/metastatic nasopharyngeal carcinoma: Preliminary results of an open-label phase II clinical study 会议论文
作者:  Xu, R.;  Wang, F. H.;  Feng, F. J.;  Li, Q.;  Xu, N.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
MicroRNA-3926 promotes apoptosis of SLE CD4+T cells through inhibiting autophagy by targeting ATG5 会议论文
作者:  Xie, L.;  Xu, J.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Atezolizumab monotherapy in Chinese patients with locally advanced or metastatic solid tumours 会议论文
作者:  Shen, L.;  Zhang, L.;  Hu, X.;  Pan, H.;  Liu, T.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Preliminary safety, pharmacokinetics (PK) and efficacy results from a phase I study of CS1001, an anti-programmed death ligand-1 (PD-L1) monoclonal antibody (mAb) in patients (pts) with advanced tumors 会议论文
作者:  Shen, L.;  Cao, J.;  Gong, J.;  Ji, D.;  Qin, Z.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace